Anna Katharina Seitz

MD, Department of Urology, Julius- Maximilians University, Würzburg, Germany; Klinikum rechts der Isar, TUM, Munich; MOMA, University of Aarhus, Denmark.

[Hannah Arnold @DrHannahArnold]

Love reading this. Waking up after a all female urology meeting in #Merklingen where I was asked to talked about equity of chances… still long ways to go … I’m optimistic that we leave manels behind - even in #urology. #KeepTalking

[Tom Powles @tompowles1]

ASCO GU bladder cancer highlights 1) EV201: Enfortumab Vedotin after relapse on immune therapy. Chemo would have response rates of 35-40% and PFS of ~6 months here in our series. EV302: a positive randomised trial of EV vs chemo after IO and chemo. Are we replacing chemo at last?

[Axel S. Merseburger @amerseburger]

CARD trial online - mCRPC sequence clear: AR - DOCE - CABA @wulfingc @uroupdate @Uromigos #ESMO19 @drenriquegrande @cnsternberg @GeSRU_de @myESMO @FabioSchutz78 https://t.co/iV8Qqjq9Ym

[Matt Cooperberg @dr_coops]

Critical #prostatecancer terminology. ⁦@declangmurphy⁩ Know your acronyms! #pcsm
⁦@MartiniKlinik⁩

[Axel S. Merseburger @amerseburger]

#EuropeanCommission announces approval of #Erleada® (#Apalutamide) For Non-Metastatic Castration-Resistant #ProstateCancer Patients Who Are At High Risk Of Developing #Metastatic Disease $JNJ #Janssen @GeSRU_de @DGUrologie https://t.co/4Xmmnp497z …

[European Urology @EUplatinum]

High responses to chemotherapy after front line immune checkpoint inhibition in #bladdercancer https://t.co/mxPXlxF0u9 @b_szabados

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Elegant work by @LDyrskjot dissecting the ctDNA in progression and therapy response for #bladdercancer @B_C_A_N https://t.co/mLX2NbfQET

[Axel S. Merseburger @amerseburger]

Roche receives EU approval of TECENTRIQ® (atezolizumab) for Cis ineligible and metastatic mBCa @Uroweb @Roche https://t.co/wQuYxsy7hw

[Polizei München @PolizeiMuenchen]

Wenn sich ein augenscheinlicher Hipster vor lauter Rausch vollgepinkelt hat, ist er dann ein Dripster? #Wiesnwache

[European Association of Urology (EAU) @Uroweb]

⚡️ Highlights from the 2017 EAU Update on Prostate Cancer in Vienna” #eauPCa17
https://t.co/D0EoDuYBJA

[Juan Gómez Rivas @JGomezRivas]

#eauPCa17 influencers. Thanks to you all urological community got the latest updates on #prostatecancer @Uroweb

[Lars Dyrskjøt @LDyrskjot]

Our new paper on #bladdercancer genomic and transcriptomic heterogeneity is now online.
https://t.co/cbih0EP37a